Proto Labs Inc
NYSE:PRLB
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
26.71
41.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Proto Labs Inc
Proto Labs Inc
Accrued Liabilities
Proto Labs Inc
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Proto Labs Inc
NYSE:PRLB
|
Accrued Liabilities
$37.5m
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
12%
|
|
|
Otis Worldwide Corp
NYSE:OTIS
|
Accrued Liabilities
$1.8B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Ingersoll Rand Inc
NYSE:IR
|
Accrued Liabilities
$644m
|
CAGR 3-Years
10%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Parker-Hannifin Corp
NYSE:PH
|
Accrued Liabilities
$1.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
4%
|
|
|
Xylem Inc
NYSE:XYL
|
Accrued Liabilities
$1.1B
|
CAGR 3-Years
33%
|
CAGR 5-Years
22%
|
CAGR 10-Years
12%
|
|
|
Illinois Tool Works Inc
NYSE:ITW
|
Accrued Liabilities
$1.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
Proto Labs Inc
Glance View
Proto Labs, Inc. engages in the digital manufacture of custom prototypes and production parts. The company is headquartered in Maple Plain, Minnesota and currently employs 2,663 full-time employees. The company went IPO on 2012-02-24. The firm's segments include United States, Europe and Japan. Its primary manufacturing product lines include injection molding, computer numerical control (CNC) machining, three dimensional (3D) printing and sheet metal. The company targets its products to product developers and engineers who use 3D computer aided design (3D CAD) software to design products across a range of end-markets. The firm's injection molding product line uses its 3D CAD-to-CNC machining technology for the automated design and manufacture of molds. Its CNC machining product line uses CNC machines to manufacture custom metal and plastic arts. Its 3D printing product line includes a range of technologies in plastics and metals, stereolithography and selective laser sintering, among others. Its sheet metal product line includes quick-turn and e-commerce-enabled custom sheet metal parts and assemblies.
See Also
What is Proto Labs Inc's Accrued Liabilities?
Accrued Liabilities
37.5m
USD
Based on the financial report for Sep 30, 2024, Proto Labs Inc's Accrued Liabilities amounts to 37.5m USD.
What is Proto Labs Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
12%
Over the last year, the Accrued Liabilities growth was -4%. The average annual Accrued Liabilities growth rates for Proto Labs Inc have been 7% over the past three years , 5% over the past five years , and 12% over the past ten years .
You don't have any saved screeners yet
